These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1135 related items for PubMed ID: 19227433

  • 21. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V, Ugur A, Colak D, Saba R, Tezcan G, Kupesiz A, Karadogan I, Gultekin M, Yesilipek A, Undar L.
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [Abstract] [Full Text] [Related]

  • 22. Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program.
    Rossini F, Terruzzi E, Cammarota S, Morini F, Fumagalli M, Verga L, Elli E, Verga M, Miccolis I, Parma M, Pogliani EM.
    Transpl Infect Dis; 2005 Aug; 7(3-4):122-5. PubMed ID: 16390400
    [Abstract] [Full Text] [Related]

  • 23. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T, Nampoory MR, Johny KV, Pacsa AS, Mini Abraham P, Nair MP, Abdel-Haleem M, Samhan M, Al-Mousawi M.
    Transplant Proc; 2004 Aug; 36(6):1847-9. PubMed ID: 15350495
    [Abstract] [Full Text] [Related]

  • 24. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C, Muñoz I, Gutiérrez A, Farga A, Prósper F, García-Conde J, Navarro D, Gimeno C.
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Monitoring low cytomegalovirus viremia in transplanted patients by a real-time PCR on plasma.
    Schvoerer E, Henriot S, Zachary P, Freitag R, Fuchs A, Fritsch S, Risch S, Meyer N, Caillard S, Lioure B, Stoll-Keller F.
    J Med Virol; 2005 May; 76(1):76-81. PubMed ID: 15778970
    [Abstract] [Full Text] [Related]

  • 28. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S, Hartmann A, Rollag H.
    Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G, Baldanti F, Torsellini M, Minoli L, Viganò M, Oggionnis T, Rampino T, Castiglioni B, Goglio A, Colledan M, Mammana C, Nozza F, Daniele L, Bergamo Transplant Group.
    Antivir Ther; 2007 Jul; 12(1):63-72. PubMed ID: 17503749
    [Abstract] [Full Text] [Related]

  • 30. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M, Ahmadi H, Baradaran N, Montaser-Kouhsari L, Salem S, Mehrsai A, Kalantar E, Jahani Y, Pourmand G.
    Transplant Proc; 2009 Sep; 41(7):2841-4. PubMed ID: 19765452
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
    De Santo LS, Romano G, Mastroianni C, Roberta C, Della Corte A, Amarelli C, Maiello C, Giannolo B, Marra C, Ragone E, Grimaldi M, Utili R, Scardone M, Cotrufo M.
    Transplant Proc; 2005 Sep; 37(6):2684-7. PubMed ID: 16182784
    [Abstract] [Full Text] [Related]

  • 35. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N, Seehofer D, Kahl A, Kokott S, Pratschke J, Frei U, Neuhaus P.
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [Abstract] [Full Text] [Related]

  • 36. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR.
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [Abstract] [Full Text] [Related]

  • 37. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F, Sechet A, Abou Ayache R, Thierry A, Belmouaz S, Desport E, Bauwens M, Bridoux F, Touchard G.
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [Abstract] [Full Text] [Related]

  • 38. Incidence and predictive factors for cytomegalovirus infection in renal transplant recipients.
    Corona-Nakamura AL, Monteón-Ramos FJ, Troyo-Sanromán R, Arias-Merino MJ, Anaya-Prado R.
    Transplant Proc; 2009 Sep; 41(6):2412-5. PubMed ID: 19715936
    [Abstract] [Full Text] [Related]

  • 39. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
    Antretter H, Höfer D, Klaus A, Larcher C, Margreiter J, Margreiter R.
    Dtsch Med Wochenschr; 2000 Apr 14; 125(15):445-51. PubMed ID: 10800441
    [Abstract] [Full Text] [Related]

  • 40. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD, Milstone AP, Miller GG, Loyd JE, Stephen Dummer J.
    Clin Transplant; 2009 Apr 14; 23(4):476-83. PubMed ID: 19453645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.